|
Medicare Audits Show Problems in Private Plans
By Robert Pear, The New York Times
October 7, 2007
Tens of thousands of Medicare recipients have been victims of deceptive
sales tactics and had claims improperly denied by private insurers that
run the system’s huge new drug benefit program and offer other private
insurance options encouraged by the Bush administration, a review of
scores of federal audits has found.
The problems, described in 91 audit reports reviewed by The New York
Times, include the improper termination of coverage for people with
H.I.V. and AIDS, huge backlogs of claims and complaints, and a failure
to answer telephone calls from consumers, doctors and drugstores.
Medicare officials have required insurance companies of all sizes to fix
the violations by adopting “corrective action plans.” Since March,
Medicare has imposed fines of more than $770,000 on 11 companies for
marketing violations and failure to provide timely notice to
beneficiaries about changes in costs and benefits.
The companies include three of the largest participants in the Medicare
market, UnitedHealth, Humana and WellPoint.
The audits document widespread violations of patients’ rights and
consumer protection standards. Some violations could directly affect the
health of patients — for example, by delaying access to urgently needed
medications. In July, Medicare terminated its contract with a private
plan in Florida after finding that it posed an “imminent and serious
threat” to its 11,000 members.
In other cases, where auditors criticized a company’s “policies and
procedures,” the effects on patients were not clear.
The audits show the growing pains that Medicare has experienced as it
introduced the popular new drug benefit and shifted more responsibility
to private health plans.
For years, Democrats have complained about efforts to “privatize
Medicare,” and they are likely to cite the findings as evidence that
private insurers cannot be trusted to care for the sickest, most
vulnerable Medicare recipients.
But federal officials point with pride to their efforts to police the
Medicare market, and they say that competition among private plans has
been a boon to beneficiaries, offering more choices at lower cost than
anyone expected.
“The Medicare drug benefit is saving seniors an average of $1,200 a
year,” said Michael O. Leavitt, the secretary of health and human
services.
Medicare officials said the audits also showed that insurers would be
held accountable.
“The start-up period is over,” said Kerry N. Weems, the new acting
administrator of the Centers for Medicare and Medicaid Services. “I am
simply not going to tolerate marketing abuses.”
The same insurance companies that offer stand-alone drug plans also sell
Medicare Advantage plans, which provide a full range of benefits
including coverage of doctor’s visits and hospital care. Enrollment in
Medicare Advantage plans has increased sharply, to more than 7.7
million, from 4.7 million in 2003. Federal auditors found the same types
of violations in both parts of the program.
Of the audits conducted by the Department of Health and Human Services,
39 focused on drug benefits, 44 focused on managed care plans and 8
examined other types of private plans.
Medicare officials said that compliance problems occurred most often in
two areas: marketing, and the handling of appeals and grievances related
to the quality of care.
Many of the marketing abuses occurred in sales of the fastest-growing
type of Medicare Advantage product, known as private fee-for-service
plans. In June, the government announced that seven of the leading
companies in this market, including UnitedHealth, Humana and Coventry,
had agreed to suspend marketing of these plans. Medicare recently
allowed them to resume marketing after they took steps to monitor their
sales agents more closely.
Each Medicare plan has a list of preferred drugs, known as a formulary.
Under federal law, patients can request coverage of other drugs that may
be medically necessary. But many insurers do not have procedures to
handle such requests, auditors said.
John H. Wells, the compliance officer at Bravo Health, defended the
company’s record, but he said: “The appeals and grievance process is
very complex. It is very difficult for any plan to be fully compliant.
In many cases, the government’s guidance is unclear, so it’s impossible
for a business to know what to do.”
These findings were typical of the deficiencies described in Medicare
audit reports:
UnitedHealth, which serves more than six million Medicare beneficiaries,
did not have an “effective program” to supervise its marketing
representatives, agents and brokers. In some cases, United improperly
denied claims without giving any explanation to beneficiaries. Peter L.
Ashkenaz, a company spokesman, said, “We terminated a few agents and
brokers for misrepresenting our products.”
WellPoint, one of the nation’s largest insurers, had “a backlog of
approximately 354,000 claims” at certain Medicare plans offered through
its UniCare subsidiary. The company’s call center took an average of 27
minutes to answer phone calls from its members and 16 minutes to answer
calls from health care providers. More than half the callers hung up
before speaking to a company representative. Karen Brown, a spokeswoman
for WellPoint, had no immediate comment.
In March, Sierra Health Services ended drug coverage for more than 2,300
Medicare beneficiaries with H.I.V./AIDS, saying they had not paid their
premiums. In many cases, the premiums had been paid, and beneficiaries
had canceled checks to prove it. Sierra initially refused to reinstate
them, but eventually agreed to do so after repeated requests from
federal officials. Peter O’Neill, a vice president of Sierra, said this
particular drug plan, which attracted people with very high drug costs,
would not be offered in 2008.
Humana, which covers more than 4.5 million people on Medicare, promised
to investigate every complaint about its marketing practices, but it
received so many complaints that it could not keep up. Many
beneficiaries said they had received incorrect information from Humana
agents. Medicare officials said some agents had not been adequately
trained or supervised. Thomas T. Noland Jr., a senior vice president of
Humana, said the company had taken “corrective action to improve the
situation.”
Humana did not always tell beneficiaries about changes in its list of
covered drugs. In some cases, Humana did not explain its reasons for
denying claims and did not inform beneficiaries of their appeal rights.
The Sterling Life Insurance Company, a subsidiary of the Aon
Corporation, did not pay claims correctly or handle appeals in a timely
way. The company has “a demonstrated pattern of failure” to meet
Medicare performance standards. Problems were compounded by a rapid
growth in enrollment. Sterling said it had taken steps to improve
compliance.
Two sponsors of popular Medicare drug plans, MemberHealth and Bravo
Health, did not act on requests for coverage of specific drugs within 72
hours, as required by the government. Bravo did not comply with federal
rules requiring doctors to review all claims denied for a “lack of
medical necessity.”
D. Alan Scantland, senior vice president of MemberHealth, a subsidiary
of the Universal American Financial Corporation, said, “We don’t believe
that we were compromising any beneficiaries’ health because of what we
were doing or not doing.”
Representative Bart Stupak, a Michigan Democrat who is chairman of the
investigations subcommittee of the House Energy and Commerce Committee,
said he had “verified countless stories of deceptive sales practices by
insurance agents who prey upon the elderly and disabled to sell them
expensive and inappropriate private Medicare plans.”
Kathleen Healey, a lawyer at the Alabama Department of Senior Services,
said: “Despite the prohibition of door-to-door marketing, agents arrive
on residents’ doorsteps stating that the president sent them, or that
they represent Medicare. Some telemarketers insist they are calling from
Medicare, and they tell beneficiaries that they will lose their Medicare
if they do not sign up for the telemarketer’s plan.”
Medicare has taken “vigorous action” to halt marketing violations, said
Abby L. Block, a Medicare official.
But David A. Lipschutz, a lawyer at California Health Advocates, a
nonprofit group, said that Medicare’s generous payments to private plans
still encouraged predatory sales practices.
“Every enrollee in a private Medicare plan is a potential source of
substantial profits,” Mr. Lipschutz said.
More Information on US Health Issues
|
|